Neuropsychiatric Symptoms in Parkinson's Disease: Review of Data from the Arab World

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2024 Dec 17

PMID 39687936

Authors

Alfred Chabbouh

Hassan Khalil

Chafic Abboud

Antoine Sader

Rita Khoury

Affiliations

Soon will be listed here.

Abstract

Neuropsychiatric symptoms in Parkinson's disease (PD) are common, underrecognized, and impact patients' quality of life. Research around this topic is scarce in the Arab world. The aim of this comprehensive narrative review was to examine available evidence and discusses its strengths and limitations. The PubMed and Embase databases were searched using relevant keywords for studies published between 2000 and 2023. A total of 10 epidemiological and three assessment tool validation studies of neuropsychiatric symptoms in PD, conducted in the 22 Arab countries, were included. Only four Arab countries contributed to the 10 epidemiological studies found. Egypt provided the largest number of patients. Prevalence rates of neuropsychiatric symptoms in PD were heterogenous. Three studies relied on the Non-Motor Symptom Scale to estimate prevalence. Three studies used validated screening tools for dementia. Five studies used specific screening tools for depression, while two used the Diagnostic and Statistical Manual of mental disorders, fourth edition (DSM-IV) diagnostic criteria for depression. No appropriate and validated tool is available to assess for apathy. The generalizability of the findings is limited and recommendations for future studies are provided.

References

Magdy R, Mohammed Z, Hassan A, Ali M, Ibrahim A, Adel S . Validation of the Arabic version of Parkinson's Disease Sleep Scale-Revised Version (PDSS-2). Rev Neurol (Paris). 2024; . DOI: 10.1016/j.neurol.2023.08.018. View

Markovic V, Stankovic I, Petrovic I, Stojkovic T, Dragasevic-Miskovic N, Radovanovic S . Dynamics of impulsive-compulsive behaviors in early Parkinson's disease: a prospective study. J Neurol. 2020; 267(4):1127-1136. DOI: 10.1007/s00415-019-09692-4. View

van Wamelen D, Martinez-Martin P, Weintraub D, Schrag A, Antonini A, Falup-Pecurariu C . The Non-Motor Symptoms Scale in Parkinson's disease: Validation and use. Acta Neurol Scand. 2020; 143(1):3-12. DOI: 10.1111/ane.13336. View

den Brok M, van Dalen J, van Gool W, Moll van Charante E, de Bie R, Richard E . Apathy in Parkinson's disease: A systematic review and meta-analysis. Mov Disord. 2015; 30(6):759-69. DOI: 10.1002/mds.26208. View

Tibar H, Bayad K, Bouhouche A, Haddou E, Benomar A, Yahyaoui M . Non-Motor Symptoms of Parkinson's Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients. Front Neurol. 2018; 9:170. PMC: 5893866. DOI: 10.3389/fneur.2018.00170. View

Weintraub D, Aarsland D, Chaudhuri K, Dobkin R, Leentjens A, Rodriguez-Violante M . The neuropsychiatry of Parkinson's disease: advances and challenges. Lancet Neurol. 2021; 21(1):89-102. PMC: 8800169. DOI: 10.1016/S1474-4422(21)00330-6. View

Faddoul L, Chahine B, Haydar S, Abourida S, Hallit S, Raad E . The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients. Pharm Pract (Granada). 2019; 16(4):1220. PMC: 6322989. DOI: 10.18549/PharmPract.2018.04.1220. View

Reijnders J, Ehrt U, Weber W, Aarsland D, Leentjens A . A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2007; 23(2):183-9. DOI: 10.1002/mds.21803. View

Forjaz M, Martinez-Martin P, Dujardin K, Marsh L, Richard I, Starkstein S . Rasch analysis of anxiety scales in Parkinson's disease. J Psychosom Res. 2013; 74(5):414-9. DOI: 10.1016/j.jpsychores.2013.02.009. View

10.

Ghaddar A, Fawaz M, Khazen G, Abdallah J, Milane A . Prevalence of depression in Parkinson's disease in a Lebanese tertiary clinic. J Clin Exp Neuropsychol. 2015; 38(1):51-8. DOI: 10.1080/13803395.2015.1087466. View

11.

Hogl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B . Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord. 2010; 25(16):2704-16. DOI: 10.1002/mds.23190. View

12.

Trenkwalder C, Kohnen R, Hogl B, Metta V, Sixel-Doring F, Frauscher B . Parkinson's disease sleep scale--validation of the revised version PDSS-2. Mov Disord. 2011; 26(4):644-52. DOI: 10.1002/mds.23476. View

13.

Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K . Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patients. Sleep Med. 2011; 12(7):711-3. DOI: 10.1016/j.sleep.2011.01.015. View

14.

Sellami L, Kacem I, Nasri A, Ben Djebara M, Sidhom Y, Gargouri A . Evaluation of an Arabic version of the non-motor symptoms scale in Parkinson's disease. Neurol Sci. 2016; 37(6):963-8. DOI: 10.1007/s10072-016-2525-x. View

15.

Zuzuarregui J, During E . Sleep Issues in Parkinson's Disease and Their Management. Neurotherapeutics. 2020; 17(4):1480-1494. PMC: 7851262. DOI: 10.1007/s13311-020-00938-y. View

16.

Khedr E, Al Attar G, Kandil M, Kamel N, Abo Elfetoh N, Ahmed M . Epidemiological study and clinical profile of Parkinson's disease in the Assiut Governorate, Egypt: a community-based study. Neuroepidemiology. 2012; 38(3):154-63. DOI: 10.1159/000335701. View

17.

Weintraub D, Caspell-Garcia C, Simuni T, Cho H, Coffey C, Aarsland D . Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020; 7(4):449-461. PMC: 7187707. DOI: 10.1002/acn3.51022. View

18.

Fernandez H, Aarsland D, Fenelon G, Friedman J, Marsh L, Troster A . Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord. 2008; 23(4):484-500. DOI: 10.1002/mds.21875. View

19.

Fenelon G, Soulas T, Zenasni F, Cleret de Langavant L . The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord. 2010; 25(6):763-6. PMC: 2891710. DOI: 10.1002/mds.22839. View

20.

McDonald W, Holtzheimer P, Haber M, Vitek J, McWhorter K, DeLong M . Validity of the 30-item geriatric depression scale in patients with Parkinson's disease. Mov Disord. 2006; 21(10):1618-22. DOI: 10.1002/mds.21023. View